<h4>Background</h4>Rearrangements of Anaplastic lymphoma kinase (<i>ALK</i>) have been discovered as a novel driver mutation in patients with non-small-cell lung cancer (NSCLC). Here, ALK is linked to non-small cell lung carcinoma.